SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Dishman Pharmaceuticals & Chemicals
Dishman Pharmaceuticals & Chemicals
BSE: 532526|NSE: DISHMAN|ISIN: INE353G01020|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Mar 27, 17:00
160.75
-0.2 (-0.12%)
VOLUME 146,213
LIVE
NSE
Mar 27, 17:00
160.60
-1.25 (-0.77%)
VOLUME 585,898
News on Dishman Pharmaceuticals & Chemicals
Select Year: 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Invest in Sun Pharma, says Mayuresh Joshi 

3.31 pm | 25 Mar 2015 |  Source: CNBC-TV18

Mayuresh Joshi of Angel Broking is of the view that one may invest in Sun Pharmaceutical Industries....

Exit JSPL, prefer Dishman Pharma: Kunal Bothra 

3.04 pm | 23 Mar 2015 |  Source: CNBC-TV18

Kunal Bothra of LKP Securities advises exiting Jindal Steel & Power and prefers Dishman Pharma....

Your Stocks: Buy/sell ideas by market experts 

2.21 pm | 23 Mar 2015 |  Source: CNBC-TV18

Watch the interview of Kunal Bothra of LKP Securities to answer all the stock queries and Kalpesh Ashar of Full Circle Financial Planners and Advisors...

Mayuresh Joshi optimistic on Dishman Pharma 

3.05 pm | 20 Mar 2015 |  Source: CNBC-TV18

Mayuresh Joshi, VP- Institution at Angel Broking is optimistic on Dishman Pharma....

Pharma will continue to outperform; avoid DLF: Sukhani 

5.07 pm | 16 Mar 2015 |  Source: CNBC-TV18

Sudarshan Sukhani also said that JSPL, which is currently trading around Rs 190 per share, is unlikely to sustain this rally....

Sun Pharma looks interesting: Mayuresh Joshi 

4.54 pm | 16 Mar 2015 |  Source: CNBC-TV18

Mayuresh Joshi of Angel Broking is of the view that Sun Pharma looks interesting....

Exit Persistent Systems, pick Dishman Pharma: Kunal Bothra 

2.58 pm | 16 Mar 2015 |  Source: CNBC-TV18

Kunal Bothra, Head of Advisory at LKP Securities is of the view that one may exit Persistent Systems and prefer Dishman Pharma....

Your Stocks: Top picks by market experts 

2.53 pm | 16 Mar 2015 |  Source: Moneycontrol.com

Watch the interview of Kunal Bothra of LKP Securities to answer all your stock queries and Kalpesh Ashar of Full Circle Financial Planners and Advisor...

Dishman Pharma confident of meeting revenue guidance: CMD

3.43 pm | 13 Mar 2015 |  Source: CNBC-TV18

The company is on track to meet their revenue guidance for the year, said JR Vyas, CMD of Dishman Pharma....

Expect 30-40% upside in Dishman Pharma: Kunal Bothra 

2.15 pm | 11 Mar 2015 |  Source: CNBC-TV18

Kunal Bothra of LKP Securities is of the view that one may see 30-40 percent upside in Dishman Pharma....

Here are some top trading ideas from Kunal Bothra 

12.46 pm | 11 Mar 2015 |  Source: CNBC-TV18

Watch the interview of Kunal Bothra of LKP Securities with Sumaira Abidi & Reema Tendulkar on CNBC-TV18, in which he shared his readings and outlook o...

See mkt support @8750, buy on dips; like Cipla: CK Narayan 

9.29 am | 10 Mar 2015 |  Source: CNBC-TV18

Among midcaps, Narayan likes Pfizer, IFB Industries and Navin Flourine....

Dishman Pharma sees Rs 100 cr debt reduction in FY16 

1.12 pm | 16 Feb 2015 |  Source: CNBC-TV18

Talking on their SEZ sale plans he said they would wait for the Budget before deciding on it, said Arpit Vyas, MD, Dishman Pharma....

Dishman Pharma consolidated Dec '14 sales at Rs 389.68 crore

1.38 pm | 14 Feb 2015 |  Source: Moneycontrol.com

Dishman Pharmaceuticals & Chemicals has reported a consolidated total income from operations of Rs 389.68 crore and a net profit of Rs 24.03 crore for...

Buy Dishman Pharma; target of Rs 217: Angel Broking

3.31 pm | 25 Nov 2014 |  Source: Moneycontrol.com

Angel Broking is bullish on Dishman Pharmaceuticals and has recommended buy rating on the stock with a target of Rs 217 in its November 17, 2014 resea...

Dishman Pharma consolidated Sep '14 sales at Rs 399.13 crore

3.51 pm | 14 Nov 2014 |  Source: Moneycontrol.com

Dishman Pharmaceuticals & Chemicals has reported a consolidated total income from operations of Rs 399.13 crore and a net profit of Rs 33.36 crore for...

Margins to pick up in H2, will meet FY15 guidance: Dishman 

1.36 pm | 14 Nov 2014 |  Source: CNBC-TV18

Dishman Pharma’s margins were down due to stock building but they are expected to pick up in the second half of this fiscal, says company MD Arpit V...

Dishman Pharma Q2 PAT down 21% at Rs 33.3 cr

1.41 pm | 13 Nov 2014 |  Source: Moneycontrol.com

The company’s net sales were up 11 percent at Rs 392.3 crore versus Rs 353 crore, Y-o-Y....

1 2
Quick Links for Dishman Pharmaceuticals & Chemicals
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.